Article
Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients
2020-03-30
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Objective</h4> To study baseline serum neurofilament light chain (sNfL) levels as a prognostic biomarker in Guillain-Barré syndrome (GBS). <h4>Methods</h4> We measured NfL using SiMoA in serum (98 samples) and CSF (24 samples) of GBS patients prospectively included in the International GBS Outcome Study (IGOS) in Spain and compared them with controls (HC). We performed multivariable regressio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2ab7fe30-c6f1-527d-988b-fe1d89b1d8c9
- DOI
- 10.1101/2020.03.24.20042200
